JP2009530348A5 - - Google Patents

Download PDF

Info

Publication number
JP2009530348A5
JP2009530348A5 JP2009500854A JP2009500854A JP2009530348A5 JP 2009530348 A5 JP2009530348 A5 JP 2009530348A5 JP 2009500854 A JP2009500854 A JP 2009500854A JP 2009500854 A JP2009500854 A JP 2009500854A JP 2009530348 A5 JP2009530348 A5 JP 2009530348A5
Authority
JP
Japan
Prior art keywords
group
formula
compound
convertible
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009500854A
Other languages
English (en)
Japanese (ja)
Other versions
JP5256189B2 (ja
JP2009530348A (ja
Filing date
Publication date
Priority claimed from GBGB0605785.5A external-priority patent/GB0605785D0/en
Application filed filed Critical
Publication of JP2009530348A publication Critical patent/JP2009530348A/ja
Publication of JP2009530348A5 publication Critical patent/JP2009530348A5/ja
Application granted granted Critical
Publication of JP5256189B2 publication Critical patent/JP5256189B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009500854A 2006-03-22 2007-03-20 M1受容体で活性を有するベンズイミダゾールおよび医薬におけるその使用 Expired - Fee Related JP5256189B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0605785.5 2006-03-22
GBGB0605785.5A GB0605785D0 (en) 2006-03-22 2006-03-22 Compounds
PCT/EP2007/052640 WO2007107567A1 (en) 2006-03-22 2007-03-20 Benzimidazoles which have activity at m1 receptor and their uses in medicine

Publications (3)

Publication Number Publication Date
JP2009530348A JP2009530348A (ja) 2009-08-27
JP2009530348A5 true JP2009530348A5 (cg-RX-API-DMAC7.html) 2010-05-06
JP5256189B2 JP5256189B2 (ja) 2013-08-07

Family

ID=36383994

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009500854A Expired - Fee Related JP5256189B2 (ja) 2006-03-22 2007-03-20 M1受容体で活性を有するベンズイミダゾールおよび医薬におけるその使用

Country Status (6)

Country Link
US (1) US20110207777A1 (cg-RX-API-DMAC7.html)
EP (1) EP1996189B1 (cg-RX-API-DMAC7.html)
JP (1) JP5256189B2 (cg-RX-API-DMAC7.html)
ES (1) ES2395532T3 (cg-RX-API-DMAC7.html)
GB (1) GB0605785D0 (cg-RX-API-DMAC7.html)
WO (1) WO2007107567A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0706168D0 (en) * 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706187D0 (en) * 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706174D0 (en) * 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706167D0 (en) * 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706164D0 (en) * 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0817982D0 (en) * 2008-10-01 2008-11-05 Glaxo Group Ltd Compounds
AU2010228902A1 (en) * 2009-03-26 2011-10-06 Mapi Pharma Limited Process for the preparation of alogliptin
CN110368375B (zh) * 2019-07-02 2021-10-01 青岛大学附属医院 用于抑郁症及相关病症的缓释组合物及其制备方法
US20250064833A1 (en) 2021-12-13 2025-02-27 Sage Therapeutics, Inc. Combination of muscarinic receptor positive modulators and nmda positive allosteric modulators

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU701127B2 (en) * 1994-10-27 1999-01-21 Merck & Co., Inc. Muscarine antagonists
US5691323A (en) * 1995-05-12 1997-11-25 Merck & Co., Inc. Muscarine antagonists
US5574044A (en) * 1994-10-27 1996-11-12 Merck & Co., Inc. Muscarine antagonists
AU7478396A (en) * 1995-10-31 1997-05-22 Merck & Co., Inc. Muscarine agonists
ES2223588T3 (es) * 1999-10-13 2005-03-01 Banyu Pharmaceutical Co., Ltd. Derivados de imidazolidinona sustituidos.
WO2004089942A2 (en) * 2001-10-02 2004-10-21 Acadia Pharmaceuticals Inc. Benzimidazolidinone derivatives as muscarinic agents
US7279490B2 (en) * 2002-06-17 2007-10-09 Merck & Co, Inc. Ophthalmic compositions for treating ocular hypertension
GB0505304D0 (en) * 2005-03-15 2005-04-20 Ds Smith Plastics Ltd Tap for liquid containers
WO2007036711A1 (en) * 2005-09-30 2007-04-05 Glaxo Group Limited BENZIMIDAZOLONES WHICH HAVE ACTIVITY AT Ml RECEPTOR
EA016286B1 (ru) * 2005-09-30 2012-03-30 Глэксо Груп Лимитед Соединения, которые обладают активностью по отношению к рецепторам м, и их применения в медицине
GB0605786D0 (en) * 2006-03-22 2006-05-03 Glaxo Group Ltd Compounds
GB0605784D0 (en) * 2006-03-22 2006-05-03 Glaxo Group Ltd Compounds
GB0706189D0 (en) * 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds

Similar Documents

Publication Publication Date Title
JP4357965B2 (ja) メタボトロピックグルタミン酸受容体−5のヘテロアリール置換ピロールモジュレーター
JP2009512635A5 (cg-RX-API-DMAC7.html)
DE60223720T2 (de) Heteroaryl-substituierte pyrazol-modulatoren des metabotropen glutamatrezeptors-5
JP4960342B2 (ja) 2位で4級炭素によって置換された1h−ベンズイミダゾール−4−カルボキサミドは強力なparp阻害薬である
JP2009510041A5 (cg-RX-API-DMAC7.html)
DE60222698T2 (de) Heteroarylsubstituierte triazolmodulatoren des metabotropen glutamatarezeptors 5
JP5795402B2 (ja) 新規抗血小板薬
JP5227796B2 (ja) 2位においてフェニルによって置換された1h−ベンズイミダゾール−4−カルボキサミドは強力なparp阻害薬である
JP2009510037A5 (cg-RX-API-DMAC7.html)
CA2624504A1 (en) Benzimidazolone compounds which have activity at m1 receptor and their uses in medicine
CZ285479B6 (cs) Piperidinové deriváty, způsob jejich výroby a farmaceutické prostředky s jejich obsahem
TW200401641A (en) 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands
WO2010074193A1 (ja) 新規2環性複素環化合物
CN1302296A (zh) 新的2-烷基取代咪唑化合物
US7393959B2 (en) Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5
JP2010539151A5 (cg-RX-API-DMAC7.html)
JP2020533352A5 (cg-RX-API-DMAC7.html)
PE20090898A1 (es) Pirrolidina-aril-eteres como antagonistas de receptor de nk3
EP1989187A1 (en) 2-(phenyl or heterocyclic) - 1h-phenanthro (9,10-d) imidazoles
BRPI0709625A2 (pt) composto, um sal farmaceuticamente aceitável do mesmo, um diastereÈmero, um enantiÈmero, ou uma mistura dos mesmos, uso de um composto, composição farmacêutica, e, métodos para a terapia de distúrbios e de doença, para o tratamento de doença ou prevenção de doenças, para o tratamento de distúrbio, e para preparar um composto
JP2005506302A (ja) ノシセプチン類似体
JP5667934B2 (ja) 新規2環性複素環化合物からなる医薬
JP2009513513A (ja) Orl−1受容体リガンドとしての置換インドール
JP2002513015A (ja) セロトニン作動薬としてのインドリル誘導体
JP5712135B2 (ja) ベンゾイミダゾール誘導体及びgabaaレセプター複合体を調節するためのそれらの使用